Compare Stocks → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:CORCOTCMKTS:MYMXOTCMKTS:NTIIOTCMKTS:PPMD Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCORCCornwall Resources$0.00$0.00$0.00▼$0.00N/A-26.16N/AN/AMYMXMymetics$0.01$0.02$0.01▼$70.00$2K1.74N/A50 shsNTIINeurobiological Technologies$0.00$0.00▼$0.00N/A13.82N/AN/APPMDProtide Pharmaceuticals$0.22$0.22$0.02▼$0.48N/A1.26,570 shsN/A10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCORCCornwall Resources0.00%0.00%0.00%0.00%-98.00%MYMXMymetics0.00%0.00%0.00%-92.31%+42.86%NTIINeurobiological Technologies0.00%0.00%0.00%0.00%0.00%PPMDProtide Pharmaceuticals0.00%0.00%0.00%0.00%0.00%Will this $2 AI stock double overnight? (Ad)It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCORCCornwall ResourcesN/AN/AN/AN/AN/AN/AN/AN/AMYMXMymeticsN/AN/AN/AN/AN/AN/AN/AN/ANTIINeurobiological TechnologiesN/AN/AN/AN/AN/AN/AN/AN/APPMDProtide PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCORCCornwall ResourcesN/AN/AN/AN/AMYMXMymeticsN/AN/AN/AN/ANTIINeurobiological TechnologiesN/AN/AN/AN/APPMDProtide PharmaceuticalsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCORCCornwall ResourcesN/AN/AN/AN/AN/AN/AMYMXMymetics$1.08M0.00N/AN/A($0.23) per share-0.04NTIINeurobiological TechnologiesN/AN/AN/AN/AN/AN/APPMDProtide PharmaceuticalsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCORCCornwall ResourcesN/AN/A0.00∞N/AN/AN/AN/AN/AMYMXMymetics-$5.06M-$0.04N/A∞N/A-1,914.40%N/A-128.84%N/ANTIINeurobiological TechnologiesN/AN/A0.00N/AN/AN/AN/AN/AN/APPMDProtide PharmaceuticalsN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCORCCornwall ResourcesN/AN/AN/AN/AN/AMYMXMymeticsN/AN/AN/AN/AN/ANTIINeurobiological TechnologiesN/AN/AN/AN/AN/APPMDProtide PharmaceuticalsN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCORCCornwall ResourcesN/AMYMXMymetics0.73%NTIINeurobiological TechnologiesN/APPMDProtide PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipCORCCornwall Resources18.40%MYMXMymetics5.13%NTIINeurobiological Technologies3.50%PPMDProtide PharmaceuticalsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCORCCornwall Resources17N/AN/ANot OptionableMYMXMymetics2150,000144,000Not OptionableNTIINeurobiological Technologies4N/AN/ANot OptionablePPMDProtide Pharmaceuticals3N/AN/ANot OptionablePPMD, CORC, MYMX, and NTII HeadlinesNo headlines for this company have been tracked by MarketBeat.comCompany DescriptionsCornwall ResourcesOTCMKTS:CORCCornwall Resources Corp., an independent oil and gas company, acquires and develops oil and gas properties located in Texas and Louisiana Gulf Coast. Cornwall Resources Corp. was formerly known as Columbia Energy Corp. and changed its name to Cornwall Resources Corp. in April 2012. The company was founded in 2006 and is based in Houston, Texas.MymeticsOTCMKTS:MYMXMymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.Neurobiological TechnologiesOTCMKTS:NTIINeurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.Protide PharmaceuticalsOTCMKTS:PPMDProtide Pharmaceuticals, Inc. discovers, develops, and commercializes technologies and processes in the areas of clinical cell therapy, regenerative medicine, transfusion medicine, cell engineering, and transplantation in the United States and internationally. It offers serum reducers, cell culture and processing products, stem cell cryopreservatives, and stem cell and regenerative research products. The company is based in Lake Zurich, Illinois. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.